| Property | Value |
|---|
|
?:abstract
|
-
PURPOSE: To review the literature on the use of povidone prior to dental treatment for the reduction of viruses in the oral cavity METHODS: PubMed and Cochrane databases published from January 2019 to June 2020 were reviewed Studies that met the inclusion criteria were reviewed by two authors separately A qualitative review of the data was performed RESULTS: There were no randomized controlled trials or clinical observation studies on the curative or preventive effect of povidone against COVID-19, but there are clinical trial protocols in the recruitment process The use of a dose between 0 2% to 2 5% is recommended four times a day for 15-30 seconds CLINICAL SIGNIFICANCE: Povidone mouthwash could be a viable solution before dental care that should be studied to reduce the viral load off COVID-19
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Use of povidone as a mouthrinse to decrease the viral load of Covid-19 before dental care: Review of the literature
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}